Recent Insider Transactions • May 11
Founder recently bought AU$111k worth of stock On the 7th of May, Simon Henry bought around 285k shares on-market at roughly AU$0.39 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$205k worth in shares. Ankündigung • Dec 07
DGL Group Limited Announces Resignation of Hanna Posa as Joint Company Secretary, Effective December 5, 2025 DGL Group Limited announced that following closure of the Company’s internal legal department, Hanna Posa has resigned from the role of Joint Company Secretary, effective December 5, 2025. Andrew Draffin will continue as the sole Company Secretary. Ankündigung • Sep 24
DGL Group Limited, Annual General Meeting, Nov 20, 2025 DGL Group Limited, Annual General Meeting, Nov 20, 2025. Reported Earnings • Sep 02
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: AU$0.086 loss per share (down from AU$0.05 profit in FY 2024). Revenue: AU$481.5m (up 3.3% from FY 2024). Net loss: AU$24.6m (down 272% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance. Ankündigung • Aug 28
DGL Group Limited to Report Fiscal Year 2025 Results on Aug 29, 2025 DGL Group Limited announced that they will report fiscal year 2025 results on Aug 29, 2025 Price Target Changed • Jun 06
Price target decreased by 14% to AU$0.47 Down from AU$0.55, the current price target is an average from 2 analysts. New target price is 22% above last closing price of AU$0.39. Stock is down 30% over the past year. The company posted earnings per share of AU$0.05 last year. Ankündigung • Jun 06
DGL Group Limited Provides Earnings Guidance for the Second Half and Full Year 2025 DGL Group Limited provided earnings guidance for the second half and full year 2025. For the second half company expects unaudited revenue for the second half of FY25 is projected to be broadly in-line with the first half of FY25. Net profit after tax in the second half of FY25 is expected to be significantly higher than in the first half.
For the full year company expects unaudited revenue to be slightly higher than FY24. However full year underlying NPAT is expected to be 55% - 65% lower than Fiscal Year 24. New Risk • Apr 08
New major risk - Revenue and earnings growth Earnings have declined by 12% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 12% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (AU$139.8m market cap, or US$84.4m). Ankündigung • Apr 01
Dgl Group Limited Announces Stepping Down of Robert Sushames as Executive Director of the Board, Effective April 1, 2025 DGL Group Limited advised that Robert Sushames will step down as an Executive Director of the Board of DGL Group, effective immediately. Mr. Sushames will provide business development and general support within the crop protection division for up to six months, to assist with continuity and ensure a smooth transition. Mr. Sushames has been an Executive Director of the Company since 1 April 2021 and has played a key role seeing the Company through its initial public offering, multiple acquisitions and its evolution into a listed company. He has brought deep industry knowledge and provided valuable leadership during a period of significant growth and diversification. Recent Insider Transactions • Mar 26
Founder recently bought AU$121k worth of stock On the 21st of March, Simon Henry bought around 256k shares on-market at roughly AU$0.47 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$2.0m worth in shares. Major Estimate Revision • Mar 19
Consensus EPS estimates fall by 40% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from AU$0.058 to AU$0.035 per share. Revenue forecast steady at AU$510.9m. Net income forecast to grow 212% next year vs 20% growth forecast for Chemicals industry in Australia. Consensus price target down from AU$0.55 to AU$0.52. Share price rose 3.3% to AU$0.47 over the past week. Recent Insider Transactions • Mar 18
Founder recently bought AU$93k worth of stock On the 14th of March, Simon Henry bought around 200k shares on-market at roughly AU$0.47 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$1.9m worth in shares. Reported Earnings • Mar 03
First half 2025 earnings released First half 2025 results: Revenue: AU$239.1m (up 10% from 1H 2024). Net loss: AU$2.20m (down 137% from profit in 1H 2024). Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in Australia. Ankündigung • Feb 28
DGL Group Limited (ASX:DGL) acquired Australian Petro Chemical Storage Pty Ltd. DGL Group Limited (ASX:DGL) agreed to acquire Australian Petro Chemical Storage Pty Ltd for AUD 5.5 million on July 3, 2024. A cash consideration of AUD 5.5 million will be paid by DGL Group Limited. As part of consideration, AUD 5.5 million is paid towards common equity of Australian Petro Chemical Storage Pty Ltd. The transaction will be funded by operating cash flow.
The acquisition price represents 2.5 x EBITDA for the last 12 months (excluding the impact of AASB16). On a post-AASB16 basis the acquisition multiple is 3.7 x EBITDA. The acquisition will be earnings accretive for DGL.
The expected completion of the transaction is October 1, 2024 to October 31, 2024.
DGL Group Limited (ASX:DGL) completed the acquisition of Australian Petro Chemical Storage Pty Ltd on the first half of 2025. Ankündigung • Feb 27
DGL Group Limited to Report First Half, 2025 Results on Feb 28, 2025 DGL Group Limited announced that they will report first half, 2025 results on Feb 28, 2025 Ankündigung • Feb 26
DGL Group Limited Announces the Appointment of Liz Smith as an Independent Non-Executive Director, Effective from 3 March 2025 DGL Group Limited announced the appointment of Liz Smith as an Independent Non-Executive Director of the Company. Ms Smith's appointment will be effective on 3 March 2025. Elizabeth (Liz) Smith is an experienced Non-Executive Director and Chair of Audit and Risk. Liz's executive career includes Corporate Finance Partner roles at William Buck and Grant Thornton, as well as audit experience at EY. Liz is also on the Board of the Australian Red Cross, Pureprofile and Nuchev. Liz has strong skills in finance and accounting, strategy, M&A, risk and governance and extensive experience advising businesses with strong growth aspirations. Liz has worked across a wide range of industries, with businesses ranging from private companies to large ASX listed entities. Liz holds a Bachelor of Commerce from the University of Melbourne and a Master of Business Administration from La Trobe University. She is a Fellow of Chartered Accountants Australia & New Zealand, a Fellow of the Financial Services Institute of Australasia, a Fellow of the Governance Institute and is a graduate of the Australian Institute of Company Directors. New Risk • Jan 08
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$159.7m (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Recent Insider Transactions • Dec 03
Founder recently bought AU$155k worth of stock On the 27th of November, Simon Henry bought around 276k shares on-market at roughly AU$0.56 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$641k. Simon has been a buyer over the last 12 months, purchasing a net total of AU$797k worth in shares. Recent Insider Transactions • Nov 01
Founder recently bought AU$641k worth of stock On the 28th of October, Simon Henry bought around 1m shares on-market at roughly AU$0.60 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Simon's only on-market trade for the last 12 months. Ankündigung • Oct 16
DGL Group Limited, Annual General Meeting, Nov 20, 2024 DGL Group Limited, Annual General Meeting, Nov 20, 2024. Board Change • Oct 02
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director John West was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 30
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: AU$0.05 (down from AU$0.061 in FY 2023). Revenue: AU$466.1m (flat on FY 2023). Net income: AU$14.3m (down 18% from FY 2023). Profit margin: 3.1% (down from 3.7% in FY 2023). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 16%. Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance. Major Estimate Revision • Sep 06
Consensus EPS estimates fall by 16%, revenue upgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from AU$511.1m to AU$538.0m. EPS estimate fell from AU$0.066 to AU$0.055 per share. Net income forecast to grow 13% next year vs 13% growth forecast for Chemicals industry in Australia. Consensus price target down from AU$0.66 to AU$0.55. Share price fell 3.0% to AU$0.49 over the past week. Ankündigung • Sep 04
DGL Group Limited (ASX:DGL completed the acquisition of Enlog Pacific Holdings Pty Ltd for AUD 2.4 million. DGL Group Limited (ASX:DGL) agreed to acquire Enlog Pacific Holdings Pty Ltd for AUD 2.4 million on May 20, 2024. The consideration consists of AUD 2 million in cash and AUD 0.35 million in common equity via the issue of DGL Group shares at a price equal to the 10-day trading VWAP immediately prior to settlement. The acquisition is conditional on regulatory approval.
DGL Group Limited (ASX:DGL completed the acquisition of Enlog Pacific Holdings Pty Ltd on September 2, 2024. The acquisition has received regulatory board approval. Price Target Changed • Sep 02
Price target decreased by 7.3% to AU$0.64 Down from AU$0.69, the current price target is an average from 4 analysts. New target price is 30% above last closing price of AU$0.49. Stock is down 42% over the past year. Reported Earnings • Aug 31
Full year 2024 earnings: Revenues miss analyst expectations Full year 2024 results: Revenue: AU$465.1m (flat on FY 2023). Net income: AU$14.1m (down 27% from FY 2023). Profit margin: 3.0% (down from 4.1% in FY 2023). Revenue missed analyst estimates by 1.9%. Revenue is forecast to grow 8.1% p.a. on average during the next 2 years, compared to a 9.7% growth forecast for the Chemicals industry in Australia. Ankündigung • Aug 29
DGL Group Limited to Report Q4, 2024 Results on Aug 30, 2024 DGL Group Limited announced that they will report Q4, 2024 results on Aug 30, 2024 New Risk • Aug 05
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$149.4m (US$96.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (3.2% net profit margin). Market cap is less than US$100m (AU$149.4m market cap, or US$96.5m). Price Target Changed • Jul 01
Price target decreased by 7.7% to AU$0.66 Down from AU$0.72, the current price target is an average from 4 analysts. New target price is 16% above last closing price of AU$0.57. Stock is down 32% over the past year. The company posted earnings per share of AU$0.068 last year. New Risk • Jun 25
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$149.4m (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (3.2% net profit margin). Market cap is less than US$100m (AU$149.4m market cap, or US$99.5m). Major Estimate Revision • Mar 04
Consensus EPS estimates fall by 27% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from AU$539.7m to AU$487.7m. EPS estimate also fell from AU$0.082 per share to AU$0.06 per share. Net income forecast to grow 22% next year vs 22% growth forecast for Chemicals industry in Australia. Consensus price target down from AU$1.22 to AU$0.76. Share price fell 38% to AU$0.64 over the past week. Price Target Changed • Feb 28
Price target decreased by 25% to AU$0.87 Down from AU$1.17, the current price target is an average from 4 analysts. New target price is 25% above last closing price of AU$0.70. Stock is down 61% over the past year. The company is forecast to post earnings per share of AU$0.062 for next year compared to AU$0.068 last year. Reported Earnings • Feb 28
First half 2024 earnings released: EPS: AU$0.021 (vs AU$0.037 in 1H 2023) First half 2024 results: EPS: AU$0.021 (down from AU$0.037 in 1H 2023). Revenue: AU$217.0m (flat on 1H 2023). Net income: AU$5.88m (down 44% from 1H 2023). Profit margin: 2.7% (down from 4.8% in 1H 2023). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Chemicals industry in Australia. Buy Or Sell Opportunity • Feb 27
Now 31% undervalued after recent price drop Over the last 90 days, the stock has fallen 26% to AU$0.61. The fair value is estimated to be AU$0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 9.4% per annum. Earnings are also forecast to grow by 15% per annum over the same time period. Ankündigung • Feb 26
DGL Group Limited to Report First Half, 2024 Results on Feb 27, 2024 DGL Group Limited announced that they will report first half, 2024 results on Feb 27, 2024 Buying Opportunity • Jan 09
Now 21% undervalued Over the last 90 days, the stock is up 7.5%. The fair value is estimated to be AU$1.08, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 9.1% per annum. Earnings is also forecast to grow by 14% per annum over the same time period. Ankündigung • Dec 01
Dgl Group Limited Announces Chief Operating Officer Changes, Effective on January 1, 2024 DGL Group Limited announced the appointment of Mr. Alex Wing as Chief Operating Officer (COO) commencing 1 January 2024. Alex will be based at the Company’s head office in Paramatta, New South Wales, and will replace the current COO, Mr. Ryan Aisher who will remain with the Company in Christchurch, overseeing New Zealand operations. Alex joined DGL in February 2023 as General Manager of Operations where he has overseen the operations of the manufacturing businesses together with integration of the acquisitions completed by the Division over the last 18 months. Prior to joining DGL, Alex was an Operations Manager with Waste Management in New Zealand. Alex holds an MBA from Massey University and a Bachelor of Science Degree from the University of Otago. Alex brings a wealth of operational experience, contract, and customer management across multiple industries. He has a proven ability to operate large scale industrial businesses and has led high performing teams across the mining, waste, and industrial chemical industries. Ryan will remain an integral member of the DGL executive where he will focus on DGL’s New Zealand operations whilst leading the continued development of ESG related reporting. Buying Opportunity • Nov 20
Now 22% undervalued Over the last 90 days, the stock is up 8.9%. The fair value is estimated to be AU$1.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 9.1% per annum. Earnings is also forecast to grow by 14% per annum over the same time period. Price Target Changed • Oct 18
Price target decreased by 14% to AU$1.18 Down from AU$1.38, the current price target is an average from 4 analysts. New target price is 48% above last closing price of AU$0.80. Stock is down 43% over the past year. The company is forecast to post earnings per share of AU$0.081 for next year compared to AU$0.068 last year. Ankündigung • Oct 16
DGL Group Limited Announces Board Changes DGL Group Limited advised the retirement of Mr. Peter Lowe as a Non-Executive Director and Chairman of the Company, effective 16 October 2023. Peter was appointed in April 2021 and assumed the role of Chairman prior to the Company's admission to quotation on the ASX and proceeded to guide the Company through its first two years as an ASX listed entity. Peter has lent his experience gained over a long and distinguished career to the Companyand was instrumental in the Company's transition from a private to public Company. Peter was also a member of the Company's Audit & Risk Management Committee and Remuneration Committee since listing in May 2021. The Board formally wishes to acknowledge the contribution of Peter as being integral member and leader of the Board and wishes him a prosperous retirement. Mr. Tim Hosking, a Non-Executive Director of the Company, will assume the role of Chairman. Tim will bring his extensive strategic, commercial and market experience with ASX listed entities to the role and has the full support of the Board. The Company intends to appoint an additional independent director in the coming months to bring appropriate skills and experience to the Board, and to increase independent representation and diversity. Ankündigung • Oct 09
DGL Group Limited, Annual General Meeting, Nov 14, 2023 DGL Group Limited, Annual General Meeting, Nov 14, 2023, at 10:00 AUS Eastern Standard Time. Location: RACV Club, 501 Bourke Street Level 2, Bayside Room 4 Melbourne Victoria Australia Agenda: To consider the financial statements, the Directors' Report and the Auditor's Report for the year ended 30 June 2023; to approve adoption of the Remuneration Report; to consider re-election of Directors; to consider other matters. Reported Earnings • Aug 30
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2023 results: EPS: AU$0.068 (down from AU$0.10 in FY 2022). Revenue: AU$466.0m (up 26% from FY 2022). Net income: AU$19.2m (down 31% from FY 2022). Profit margin: 4.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates by 32%. Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Chemicals industry in Australia. Major Estimate Revision • Aug 29
Consensus EPS estimates fall by 15%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from AU$492.9m to AU$533.4m. EPS estimate fell from AU$0.096 to AU$0.081 per share. Net income forecast to shrink 19% next year vs 7.7% decline forecast for Chemicals industry in Australia. Consensus price target down from AU$1.32 to AU$1.28. Share price was steady at AU$0.79 over the past week. Ankündigung • Aug 28
Dgl Group Limited Announces Board Changes, Effective from 31 August 2023 DGL Group Limited announced that as part of an orderly succession plan of the DGL Group Board, Ms Denise Brotherton and Mr. Robert McKinnon have tendered their resignations as Non-Executive Directors effective from 31 August 2023. The Company announced the appointment of Mr. Tim Hosking and Mr. John West as Non-Executive Directors, effective 31 August 2023. Both Denise & Bob were appointed Directors in April 2021 prior to the Company's admission to quotation on the ASX and proceeded to guide the Company through its first two years as an ASX listed entity. Denise also served as Chair of the Audit & Risk Management Committee and Bob served as Chair of the Remuneration & Nomination Committee. Tim has over 25 years' experience providing strategic, commercial and capital markets advice to public and private companies in Australia, UK and North America. A relationship driven, trusted strategic adviser to business owners, executives and boards, with extensive experience across a wide range of industries including industrials, technology, biotech and healthcare and financial services. Tim was most recently Managing Director Investment Banking at Canaccord Genuity (Australia), previous roles include Head of Strategy ANZ Institutional Bank, Director JP Morgan Australia, and Head of Strategy AXA Australia. Tim is a graduate member of the Australian Institute of Company Directors and holds a Bachelor of Mechanical Engineering (Hons), and Bachelor of Economics (Accounting) from the University of Adelaide. John West has previously been associated indirectly with the Group having sold his successful warehousing and distribution business to the Group in 2018, Dangerous Goods Logistics. John has over 50 years' experience in the Transport and Logistics Industry and currently serves as Managing Director of John West Logistics Pty Ltd, which specialises in Contract Logistics, running a fleet of 200+ vehicles throughout Australia and New Zealand. John West Logistics is not in direct competition with DGL, and no conflict of interest will arise between the parties as a result of John's appointment. John held a seat on the Queensland Rail board for five years and his input continues to be sought from time to time by Government and other advisory bodies or committees. Ankündigung • Aug 18
DGL Group Limited to Report Fiscal Year 2023 Results on Aug 28, 2023 DGL Group Limited announced that they will report fiscal year 2023 results on Aug 28, 2023 Buying Opportunity • Jul 31
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 41%. The fair value is estimated to be AU$1.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 16% in 2 years. Earnings is forecast to decline by 1.7% in the next 2 years. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to AU$1.05, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in Australia. Total loss to shareholders of 57% over the past year. Simply Wall St's valuation model estimates the intrinsic value at AU$1.07 per share. Recent Insider Transactions • Jun 28
Board Member recently bought AU$98k worth of stock On the 26th of June, Robert Sushames bought around 150k shares on-market at roughly AU$0.65 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$714k more in shares than they have sold in the last 12 months. Buying Opportunity • Jun 19
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 52%. The fair value is estimated to be AU$1.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 16% in 2 years. Earnings is forecast to decline by 6.7% in the next 2 years. Major Estimate Revision • Jun 16
Consensus EPS estimates fall by 17% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from AU$493.0m to AU$462.6m. EPS estimate also fell from AU$0.11 per share to AU$0.092 per share. Net income forecast to shrink 5.5% next year vs 2.1% growth forecast for Chemicals industry in Australia . Consensus price target down from AU$2.23 to AU$1.64. Share price fell 29% to AU$0.83 over the past week. Ankündigung • Jun 15
DGL Group Limited Provides Earnings Guidance for Fiscal Year 2023 DGL Group Limited provided earnings guidance for Fiscal year 2023. For the year, the company expects revenue to exceed $450 million. Recent Insider Transactions • Mar 11
Founder recently bought AU$100k worth of stock On the 8th of March, Simon Henry bought around 55k shares on-market at roughly AU$1.84 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$2.0m worth in shares. Major Estimate Revision • Mar 07
Consensus revenue estimates increase by 17%, EPS downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$434.1m to AU$508.0m. EPS estimate unchanged at AU$0.111. Net income forecast to grow 12% next year vs 23% growth forecast for Chemicals industry in Australia. Consensus price target up from AU$2.19 to AU$2.30. Share price rose 6.4% to AU$1.84 over the past week. Reported Earnings • Mar 01
First half 2023 earnings released: EPS: AU$0.037 (vs AU$0.032 in 1H 2022) First half 2023 results: EPS: AU$0.037 (up from AU$0.032 in 1H 2022). Revenue: AU$217.2m (up 52% from 1H 2022). Net income: AU$10.4m (up 22% from 1H 2022). Profit margin: 4.8% (down from 6.0% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Chemicals industry in Australia. Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to AU$1.74, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in Australia. Total loss to shareholders of 36% over the past year. Simply Wall St's valuation model estimates the intrinsic value at AU$2.73 per share. Ankündigung • Jan 19
DGL Group Limited (ASX:DGL) agreed to acquire Nightingale Transport for AUD 18.2 million. DGL Group Limited (ASX:DGL) agreed to acquire Nightingale Transport for AUD 18.2 million on January 19, 2023. The acquisition price of AUD 18.2 million represents 3.7x EBITDA of AUD 4.9 million and 1.1x net tangible assets of AUD 15.2 million. The acquisition will be funded with cash, with DGL's net debt position remaining conservative. Acquisition of Nightingale Transport boosts DGL’s national logistics reach and enhances offering to target industries. The acquisition is contingent upon the fulfillment of certain contractual conditions by the vendors, which are expected to be met by the proposed settlement date. The acquisition is expected to be immediately EPS accretive, pre-synergies. Board Change • Nov 16
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Founder, Executive Director & CEO Simon Henry is the most experienced director on the board, commencing their role in 2012. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Nov 07
DGL Group Limited Announces CFO Changes DGL Group Limited announced the appointment of a new Chief Financial Officer, Rob Perkins. Rob is a Chartered Accountant with over 25 years' experience and a proven record of driving strategic initiatives and achieving positive results across the organisation. Rob holds a Bachelor of Engineering (Hons) Chem Engineering and post graduate qualifications in Business. Rob will commence in January 2023 and will join the senior leadership team. This appointment follows the decision of current CFO Ben Halsey to resign from his position to pursue other opportunities. Ben will step down from his role at the end of December and the transition process will begin shortly. DGL will ensure there is a smooth handover. Ankündigung • Nov 02
DGL Group Limited (ASX:DGL) completed the acquisition of Acacia Ridge Container Park. DGL Group Limited (ASX:DGL) agreed to acquire Acacia Ridge Container Park for AUD 5 million on August 30, 2022. The consideration includes AUD 3.5 million in cash and AUD 1.5 million priced at a 5-day VWAP up to settlement date. Settlement date is expected to be around 1 November 2022. The acquisitions are subject to contractual conditions being met by the Vendors.
DGL Group Limited (ASX:DGL) completed the acquisition of Acacia Ridge Container Park on November 2, 2022. As part of the acquisition, DGL has issued 1,000,000 fully paid ordinary shares to the vendors of Acacia Ridge as part consideration, the shares are subject to twelve-months escrow from the date of issue. Valuation Update With 7 Day Price Move • Oct 27
Investor sentiment improved over the past week After last week's 18% share price gain to AU$1.53, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry globally. Total loss to shareholders of 49% over the past year. Ankündigung • Oct 14
DGL Group Limited, Annual General Meeting, Nov 15, 2022 DGL Group Limited, Annual General Meeting, Nov 15, 2022, at 10:30 AUS Eastern Standard Time. Location: RACV Club 501 Bourke Street Level 2, Bayside Room 4a Melbourne Victoria Australia Agenda: To consider Financial statements and reports; to consider Adoption of the Remuneration Report; to consider Re-election of Directors; to consider Ratification of prior issue of securities to Austech Chemicals Pty Ltd; to consider Ratification of prior issue of securities to Australian Logistics Management Pty Ltd as trustee for the ALM Unit Trust; to consider Ratification of prior issue of securities to shareholders of RLA Polymers NZ Limited; to consider Ratification of prior issue of securities to Total Bio Group Pty Ltd; to consider Ratification of prior issue of securities to Flexichem Australia Pty Ltd vendors; to consider Ratification of prior issue of securities to Clarkson Freightlines Pty Ltd as trustee for the Clarkson and Connolly Transport Trust; to consider Ratification of prior issue of securities to BTX Group Pty Ltd vendors; and to consider other matters. Ankündigung • Sep 07
DGL Group Limited (ASX:DGL completed the acquisition of Clarkson Freightlines Pty Ltd. DGL Group Limited (ASX:DGL) entered into an agreement to acquire Clarkson Freightlines Pty Ltd for AUD 6.75 million on August 30,2022. The consideration will be paid AUD 6.25 million in cash and AUD 0.5 million priced at a 5-day VWAP up to settlement date. Settlement date is expected to be around September 5, 2022.
DGL Group Limited (ASX:DGL completed the acquisition of Clarkson Freightlines Pty Ltd on September 6, 2022. Recent Insider Transactions • Sep 06
Founder recently bought AU$500k worth of stock On the 2nd of September, Simon Henry bought around 318k shares on-market at roughly AU$1.57 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$2.4m worth in shares. Reported Earnings • Sep 01
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: EPS: AU$0.10 (down from AU$0.78 in FY 2021). Revenue: AU$369.8m (up 139% from FY 2021). Net income: AU$27.9m (down 41% from FY 2021). Profit margin: 7.5% (down from 31% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.5%. Earnings per share (EPS) missed analyst estimates by 14%. Over the next year, revenue is forecast to grow 16%, compared to a 11% growth forecast for the Chemicals industry in Australia. Ankündigung • Sep 01
DGL Group Limited (ASX:DGL) agreed to acquire Acacia Ridge Container Park for AUD 5 million. DGL Group Limited (ASX:DGL) agreed to acquire Acacia Ridge Container Park for AUD 5 million on August 30, 2022. The consideration includes AUD 3.5 million in cash and AUD 1.5 million priced at a 5-day VWAP up to settlement date. Settlement date is expected to be around 1 November 2022. Price Target Changed • Sep 01
Price target decreased to AU$3.58 Down from AU$3.97, the current price target is an average from 3 analysts. New target price is 131% above last closing price of AU$1.55. Stock is down 31% over the past year. Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment deteriorated over the past week After last week's 34% share price decline to AU$1.84, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 24x in the Chemicals industry in Australia. Total loss to shareholders of 20% over the past year. Ankündigung • Aug 17
DGL Group Limited to Report Fiscal Year 2022 Results on Aug 31, 2022 DGL Group Limited announced that they will report fiscal year 2022 results on Aug 31, 2022 Price Target Changed • Aug 15
Price target decreased to AU$3.97 Down from AU$4.32, the current price target is an average from 3 analysts. New target price is 50% above last closing price of AU$2.65. Stock is up 35% over the past year. The company is forecast to post earnings per share of AU$0.12 for next year compared to AU$0.78 last year. Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improved over the past week After last week's 19% share price gain to AU$2.82, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in Australia. Total returns to shareholders of 117% over the past year. Simply Wall St's valuation model estimates the intrinsic value at AU$3.90 per share. Buying Opportunity • May 09
Now 25% undervalued Over the last 90 days, the stock is up 7.0%. The fair value is estimated to be AU$3.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 85% in 2 years. Earnings is forecast to decline by 32% in the next 2 years. Valuation Update With 7 Day Price Move • May 06
Investor sentiment deteriorated over the past week After last week's 16% share price decline to AU$3.30, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 32x in the Chemicals industry in Australia. Simply Wall St's valuation model estimates the intrinsic value at AU$3.84 per share. Major Estimate Revision • Apr 27
Consensus EPS estimates increase by 30% The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from AU$346.6m to AU$356.5m. EPS estimate increased from AU$0.09 to AU$0.12 per share. Net income forecast to shrink 39% next year vs 34% growth forecast for Chemicals industry in Australia . Consensus price target up from AU$3.70 to AU$4.32. Share price fell 4.8% to AU$3.95 over the past week. Board Change • Apr 27
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Founder, Executive Director & CEO Simon Henry is the most experienced director on the board, commencing their role in 2012. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Apr 21
Consensus EPS estimates increase by 29% The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from AU$346.6m to AU$357.1m. EPS estimate increased from AU$0.09 to AU$0.12 per share. Net income forecast to shrink 39% next year vs 34% growth forecast for Chemicals industry in Australia . Consensus price target up from AU$3.70 to AU$4.38. Share price rose 19% to AU$4.15 over the past week. Valuation Update With 7 Day Price Move • Apr 19
Investor sentiment improved over the past week After last week's 16% share price gain to AU$3.79, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 32x in the Chemicals industry in Australia. Simply Wall St's valuation model estimates the intrinsic value at AU$5.86 per share. Recent Insider Transactions • Mar 19
Founder recently bought AU$1.4m worth of stock On the 16th of March, Simon Henry bought around 500k shares on-market at roughly AU$2.86 per share. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$2.1m worth in shares. Reported Earnings • Feb 28
First half 2022 earnings: EPS exceeds analyst expectations First half 2022 results: EPS: AU$0.032. Revenue: AU$143.0m (up 182% from 1H 2021). Net income: AU$8.55m (up 185% from 1H 2021). Profit margin: 6.0% (up from 5.9% in 1H 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1,980%. Over the next year, revenue is forecast to grow 56%, compared to a 16% growth forecast for the industry in Australia. Major Estimate Revision • Feb 11
Consensus revenue estimates increase by 34% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from AU$260.7m to AU$350.0m. EPS estimate increased from AU$0.07 to AU$0.08 per share. Net income forecast to shrink 54% next year vs 30% growth forecast for Chemicals industry in Australia . Consensus price target up from AU$3.18 to AU$3.43. Share price rose 9.1% to AU$2.99 over the past week. Recent Insider Transactions • Dec 25
Founder recently bought AU$499k worth of stock On the 20th of December, Simon Henry bought around 178k shares on-market at roughly AU$2.80 per share. This was the largest purchase by an insider in the last 3 months. Simon has been a buyer over the last 12 months, purchasing a net total of AU$621k worth in shares. Recent Insider Transactions Derivative • Dec 10
Founder exercised options to buy AU$7.3m worth of stock. On the 3rd of December, Simon Henry exercised options to buy 3m shares at a strike price of around AU$2.40, costing a total of AU$7.1m. This transaction amounted to 2.0% of their direct individual holding at the time of the trade. Since June 2021, Simon's direct individual holding has increased from 147.30m shares to 150.24m. Company insiders have collectively bought AU$7.2m more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Sep 03
Full year 2021 earnings released: EPS AU$0.78 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$154.5m (up 149% from FY 2020). Net income: AU$47.2m (up AU$45.0m from FY 2020). Profit margin: 31% (up from 3.5% in FY 2020). 
